Sub-chronic toxicity study of a novel herbal-based formulation (Semelil) on dogs

Daru

Volumn 16, Issue SUPPL. 1, 2008, Pages 15-19

  Farzamfar, B ^a   Abdollahi, M ^b   Ka'abinejadian, S ^a   Heshmat, R ^c   Shahhosseiny, M H ^d   Novitsky, Y A ^e   Farhadi, M ^f  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e European Asian Nanomolecular Technology Center   (Russian Federation)

^f IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ANGIPARS ; Dogs; Melilotus officinalis; Semelil; Toxicology

Indexed keywords

ANGIPARS; HERBACEOUS AGENT; SEMELIL; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APPETITE; ARTICLE; BEHAVIOR; BLOOD EXAMINATION; CHEMICAL ANALYSIS; CHRONIC TOXICITY; CONTROLLED STUDY; DOG; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; FUNCTIONAL STATUS; GENERAL CONDITION; HAIR ANALYSIS; HISTOPATHOLOGY; MALE; MOTOR ACTIVITY; NONHUMAN; RECTUM TEMPERATURE; TOXICITY TESTING; WEIGHT CHANGE;

EID: 38949113692     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA. Casual pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999; 22: 157-62.
2. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990; 13: 513-21.
3. th Camillo Golgi lecture. Diabetologia 2004; 47: 1343-53.
4. Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus. A case-control study. Ann Intern Med 1992; 117: 97-105.
5. Morris AD, McAlpine R, Steinke D, Boyle DI, Ebrahim AR, Vasudev N, Stewart CP, Jung RT, Leese GP, MacDonald TM, Newton RW. Diabetes and lower-limb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tay-side Scotland/Medicines Monitoring Unit. Diabetes Care 1998; 21: 738-43.
6. Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyorala K. Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland. Diabetes Care 1993; 16: 16-20.
7. Plesca-Manea L, Pârvu AE, Pârvu M, Taǎmas M, Buia R. Effects of Melilotus officinalis on acute inflammation. Phytotherapy. Res. 2002; 16: 316-19.
8. Asres A, Eder U, Bucar F. Studies on the anti-inflammatory activity of extracts and compounds from the leaves of Melilotus elegans. Ethiopian Pharmaceutic. J. 2000; 18: 15-24.
9. Vettorello G, Cerreta G, Derwish A, Cataldi A, Schettino A, Occhionorelli S, Donini I. Contribution of a combination of alpha and beta benzopyrones, flavonoids and natural terpenes in the treatment of lymphedema of the lower limbs at the 2d stage of the surgical classification. Minerva Cardioangiol. 1996; 44: 447-55.
10. EEC Council Directive 86/609/EEC on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official Journal, 29, L358, 18th December 1986.
11. National Research Council, 1985. Guide for the care and use of laboratory animals. NIH Publication No. 86-23. Washington D.C., US. Dept. of Health and Human Services.
12. GV-SOLAS (Society for Laboratory Animal Science, Gesellschaft für Versuchstierkunde, December, 1989). Publication on the Planning and Structure of Animal Facilities for Institutes Performing Animal Experiments. ISBN 3-906255-06-9.
13. nd Edition Raven Press, New York, p221-226.
14. Sorrentinoa L, Capassob A, Schmidt M. Safety of ethanolic kava extract: Results of a study of chronic toxicity in rats Phytomedicine 2006;13: 542-549.
15. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 2005; 59(7):365-73.